IN2014DN07927A - - Google Patents
Info
- Publication number
- IN2014DN07927A IN2014DN07927A IN7927DEN2014A IN2014DN07927A IN 2014DN07927 A IN2014DN07927 A IN 2014DN07927A IN 7927DEN2014 A IN7927DEN2014 A IN 7927DEN2014A IN 2014DN07927 A IN2014DN07927 A IN 2014DN07927A
- Authority
- IN
- India
- Prior art keywords
- biorelevant
- fasted state
- fatty acid
- sodium
- homogeneous
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
- G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
- G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
- G09B23/30—Anatomical models
- G09B23/303—Anatomical models specially adapted to simulate circulation of bodily fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
- G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
- G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
- G09B23/30—Anatomical models
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Computational Mathematics (AREA)
- Pure & Applied Mathematics (AREA)
- Business, Economics & Management (AREA)
- Mathematical Optimization (AREA)
- Algebra (AREA)
- Medical Informatics (AREA)
- Mathematical Analysis (AREA)
- Educational Administration (AREA)
- Educational Technology (AREA)
- Theoretical Computer Science (AREA)
- Mathematical Physics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Fodder In General (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12162548.7A EP2645099A1 (en) | 2012-03-30 | 2012-03-30 | Biorelevant compositions |
| PCT/EP2013/056945 WO2013144374A1 (en) | 2012-03-30 | 2013-04-02 | Biorelevant compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN07927A true IN2014DN07927A (pt) | 2015-05-01 |
Family
ID=48143258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN7927DEN2014 IN2014DN07927A (pt) | 2012-03-30 | 2013-04-02 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20150064794A1 (pt) |
| EP (2) | EP2645099A1 (pt) |
| JP (1) | JP6348480B2 (pt) |
| KR (1) | KR20140144255A (pt) |
| CN (1) | CN104582689A (pt) |
| BR (1) | BR112014024256A8 (pt) |
| CA (1) | CA2867638A1 (pt) |
| IN (1) | IN2014DN07927A (pt) |
| MX (1) | MX357927B (pt) |
| NZ (1) | NZ700064A (pt) |
| WO (1) | WO2013144374A1 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108619089A (zh) * | 2011-08-23 | 2018-10-09 | 凯瑟拉生物制药有限公司 | 脱氧胆酸和其盐的制剂 |
| WO2019199238A1 (en) * | 2018-04-09 | 2019-10-17 | Vet Products Research And Innovation Center Company Limited | Inorganic mineral entrapped in nanoparticle production method thereof |
| GB201809627D0 (en) * | 2018-06-12 | 2018-07-25 | Biorelevant Com Ltd | Methods for preparing buffer solutions suitable for in vitro drug dissolution testing, drug solubility testing and/or drug profiling |
| GB201904757D0 (en) * | 2019-04-04 | 2019-05-22 | Biorelevant Com Ltd | Biorelevant composition |
| CN115053295A (zh) | 2020-02-19 | 2022-09-13 | 拜耳公司 | 预测制剂特性 |
| GB202112975D0 (en) | 2021-09-10 | 2021-10-27 | Biorelevant Com Ltd | Biorelevant dissolution compositions with reproducible spectral profiles |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4874795A (en) * | 1985-04-02 | 1989-10-17 | Yesair David W | Composition for delivery of orally administered drugs and other substances |
| GB8909022D0 (en) * | 1989-04-20 | 1989-06-07 | Cortecs Ltd | Pharmaceutical compositions |
| US6040188A (en) * | 1997-11-18 | 2000-03-21 | The Regents Of The University Of California | In vitro gastrointestinal mimetic protocol for measuring bioavailable contaminants |
| IT1296914B1 (it) * | 1997-12-01 | 1999-08-03 | Maria Rosa Gasco | Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera |
| WO2003042392A1 (en) * | 2001-11-15 | 2003-05-22 | Phares Pharmaceutical Research N.V. | Standardised phospholipid mixtures |
| MXPA06010950A (es) * | 2004-03-26 | 2007-04-16 | Cell Therapeutics Europe Srl | Formulaciones en nano-particulas de compuestos de platino. |
| GB0522942D0 (en) * | 2005-11-10 | 2005-12-21 | Leigh Steven | Dissolution composition |
| BRPI0707336A2 (pt) * | 2006-01-27 | 2011-05-03 | Danisco | uso de microorganismos probióticos para o tratamento e prevenção de obesidade e distúrbios relacionados |
| WO2008040799A2 (en) | 2006-10-06 | 2008-04-10 | Boehringer Ingelheim International Gmbh | Process for preparing instant forms of aqueous mixed micellar solutions as physiological buffer systems for use in the analysis of in vitro release |
-
2012
- 2012-03-30 EP EP12162548.7A patent/EP2645099A1/en not_active Ceased
-
2013
- 2013-04-02 NZ NZ700064A patent/NZ700064A/en not_active IP Right Cessation
- 2013-04-02 CA CA2867638A patent/CA2867638A1/en not_active Abandoned
- 2013-04-02 JP JP2015502383A patent/JP6348480B2/ja not_active Expired - Fee Related
- 2013-04-02 EP EP13717734.1A patent/EP2830592A1/en not_active Withdrawn
- 2013-04-02 WO PCT/EP2013/056945 patent/WO2013144374A1/en active Application Filing
- 2013-04-02 KR KR1020147030491A patent/KR20140144255A/ko not_active Application Discontinuation
- 2013-04-02 MX MX2014011789A patent/MX357927B/es active IP Right Grant
- 2013-04-02 US US14/389,701 patent/US20150064794A1/en not_active Abandoned
- 2013-04-02 IN IN7927DEN2014 patent/IN2014DN07927A/en unknown
- 2013-04-02 CN CN201380018498.8A patent/CN104582689A/zh active Pending
- 2013-04-02 BR BR112014024256A patent/BR112014024256A8/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2830592A1 (en) | 2015-02-04 |
| JP6348480B2 (ja) | 2018-06-27 |
| US20150064794A1 (en) | 2015-03-05 |
| EP2645099A1 (en) | 2013-10-02 |
| CA2867638A1 (en) | 2013-10-03 |
| BR112014024256A8 (pt) | 2018-02-06 |
| JP2015524913A (ja) | 2015-08-27 |
| BR112014024256A2 (pt) | 2017-06-20 |
| KR20140144255A (ko) | 2014-12-18 |
| WO2013144374A1 (en) | 2013-10-03 |
| MX357927B (es) | 2018-07-27 |
| NZ700064A (en) | 2016-08-26 |
| MX2014011789A (es) | 2015-06-03 |
| CN104582689A (zh) | 2015-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN07927A (pt) | ||
| GB201212223D0 (en) | Electrical connectors | |
| MY160275A (en) | Nutritional compositions with lipid globules with a core comprising vegetable lipids and a coating comprising phospholipids or polar lipids | |
| WO2006114790A3 (en) | Polar lipid mixtures, their preparation and uses | |
| RU2010129985A (ru) | Композиции питательного порошка и детской питательной смеси (варианты) | |
| WO2011114239A3 (en) | Fat-binding compositions | |
| IN2014DN03449A (pt) | ||
| Benelhadj et al. | Properties of lysozyme/Arthrospira platensis (Spirulina) protein complexes for antimicrobial edible food packaging | |
| ATE524978T1 (de) | Zusammensetzung zur reduzierung des nacl-gehaltes in lebensmitteln | |
| WO2009143133A3 (en) | Compositions and methods to protect cells by blocking entry of pathogen proteins | |
| TR201911096T4 (tr) | Yumuşak kapsüller için kabuk oluşturma kompozisyonları ve yumuşak kapsüller. | |
| WO2008011272A3 (en) | Liquid monophasic lipid-soluble antioxidant compositions and processes for making the compositions | |
| MA38371A1 (fr) | Matériau hybride organique-inorganique, utile pour extraire l'uranium(vi) de milieux aqueux comprenant de l'acide phosphorique, ses procédés de préparation et ses utilisations | |
| BR112013010134A2 (pt) | pedaços de peixe fabricados | |
| WO2014088830A3 (en) | Screening of nucleic acid agents via particle display | |
| Alkalbani et al. | Assessment of yeasts as potential probiotics: A review of gastrointestinal tract conditions and investigation methods | |
| PH12019502410A1 (en) | Encapsulated nutritional and pharmaceutical compositions | |
| WO2007007269A3 (en) | Agglutinant compound and agglutinated product for reconstituting powders of vegetal origin | |
| MY159390A (en) | Nutritional composition for infants | |
| WO2009062995A3 (en) | Preparation of epsilon copper phthalocyanine of small primary particle size and narrow particle size distribution by kneading | |
| Pedersen et al. | The degradation of arabinoxylan-rich cell walls in digesta obtained from piglets fed wheat-based diets varies depending on digesta collection site, type of cereal, and source of exogenous xylanase | |
| MY171963A (en) | Nutritional composition comprising whey and hydrolyzed casein and uses thereof | |
| BR112013030032A2 (pt) | sistema e método de fabricação com o uso de uma estrutura virtual de referência | |
| Zhou et al. | Dairy processing affects the gut digestion and microecology by changing the structure and composition of milk fat globules | |
| CL2009001888A1 (es) | Formula nutricional que tiene un ph en el estado liquido de 4,8 a 5,2, que comprende 1 a 1,2% de acido lactico y entre 0,9 a 1,4% de una sal de acido lactico, seleccionada de lactato de sodio, de potasio o de calcio. |